A protein that regulates height could be used to treat diseases such as cancer and diabetes, according to new Australian research.
The study uncovered how a particular receptor that controls the growth hormone for height is switched on and off.
Lead researcher Professor Mike Waters said people without the growth hormone’s receptor don’t appear to die from cancer or diabetes.
The findings may lead to the creation of medication that binds to the hormone’s receptor, switching it on and off as appropriate.
Read more at The University of Queensland